Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
I-Stem logo — company profile

I-Stem

Founded 2005 France France 88 employees Biotechnology, Health Care +1

General Information

Company Name I-Stem
Founded Year 2005
Location France France +1
Employees 88
Industries Biotechnology, Health Care, Marketing
Social

Get notified when I-Stem moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About I-Stem

I-Stem is the largest French laboratory dedicated to human pluripotent stem cells, established in 2005 through a collaboration between Inserm and AFM-Telethon. The institute's focus lies in exploring the therapeutic potential of human pluripotent stem cells for rare genetic diseases. Its research is primarily concentrated on two main areas - cell therapy, which intends to replace lost or diseased cells with those of the same characteristics produced from pluripotent stem cells, and pharmacology, involving the screening of compounds with therapeutic potential based on molecular mechanisms associated with diseases. Currently, I-Stem is working on around a dozen genetic diseases affecting various organs. Moreover, it provides training, technology support, and hosts researchers interested in other diseases annually. The institute's unique positioning within the biotechnology, health care, and marketing industries makes it a compelling entity for investors seeking opportunities in groundbreaking medical research and biotechnological advancements. While the specific details regarding the latest investment and participating investors are not available, I-Stem offers a promising prospect for venture capitalists looking to contribute to the field of rare disease treatment and human pluripotent stem cell research.

No funding data available for I-Stem yet.

Get notified when I-Stem raises funding

I-Stem Alternatives & Competitors

I-Stem vs
Genethon
Genethon France

Généthon, centre de R&D préclinique et clinique de médicaments de thérapie génique.

294 employees
I-Stem vs
Anagenesis Biotechnologies
Anagenesis Biotechnologies France

Development of new regenerative medicines

2-10 employees
Biotechnology
I-Stem vs
Sanford Stem Cell Discovery Center
Sanford Stem Cell Discovery Center United States

Increasing hope and cures through stem cell basic and clinical research.

1 employees
Biopharma, Education

FAQ About I-Stem

Created in 2005 through a collaboration between Inserm – Institut National Health and Medical Research – and AFM-Telethon – French Association against Myopathies – I-Stem is the largest French laboratory research and development dedicated to human pluripotent stem cells, embryonic origin or obtained...
I-Stem was founded in 2005.
I-Stem is headquartered in France.
I-Stem operates in the following industries: Biotechnology, Health Care, Marketing.
I-Stem has approximately 88 employees.
Top alternatives and competitors to I-Stem include Genethon, Anagenesis Biotechnologies, Sanford Stem Cell Discovery Center, Kangstem Biotech Co., Ltd., RiboNova, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
I-Stem and Genethon are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors I-Stem and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy